Avant Diagnostics, Inc. Corporate Update
08 mai 2019 15h28 HE
|
Avant Diagnostics, Inc.
Washington, DC, May 08, 2019 (GLOBE NEWSWIRE) -- Avant Diagnostics, Inc. hereby provides the following corporate update to the Company’s shareholders. A copy of the update can also be found on the...
AVANT DIAGNOSTICS COMMENTS ON HALT OF TRADING OF COMMON STOCK
24 sept. 2018 09h38 HE
|
Avant Diagnostics, Inc.
Washington, DC, Sept. 24, 2018 (GLOBE NEWSWIRE) -- Avant Diagnostics, Inc. ("Avant" or the “Company”) (OTC Pink: AVDX), announced today that trading in its common stock has been temporarily...
Avant Diagnostics Presented Data on TheraLink® Pancreatic Cancer Assay at the International Symposium on Pancreas Cancer 2016
14 juin 2016 09h00 HE
|
Avant Diagnostics, Inc.
SCOTTSDALE, Ariz. and GAITHERSBERG, Md., June 14, 2016 (GLOBE NEWSWIRE) -- Avant Diagnostics, Inc. (“Avant”) (OTCQB:AVDX), an innovative molecular diagnostics company, today announced that Dr. Vince...
Avant Diagnostics to Present at Upcoming Investor Conferences
31 mai 2016 09h00 HE
|
Avant Diagnostics, Inc.
SCOTTSDALE, Ariz. and GAITHERSBERG, Md., May 31, 2016 (GLOBE NEWSWIRE) -- Avant Diagnostics, Inc. (“Avant”) (OTCQB:AVDX), an innovative molecular diagnostics company, today announced that Company...
Avant Diagnostics Announces Data Presentations at 2016 ASCO Annual Meeting
19 mai 2016 09h15 HE
|
Avant Diagnostics, Inc.
SCOTTSDALE, Ariz. and GAITHERSBERG, Md., May 19, 2016 (GLOBE NEWSWIRE) -- Avant Diagnostics, Inc. (“Avant”) (OTCQB:AVDX), an innovative molecular diagnostics company, today announced the acceptance...
Avant Diagnostics Simultaneously Completes Acquisitions of Amarantus Diagnostics and Theranostics Health
12 mai 2016 07h30 HE
|
Avant Diagnostics, Inc.
Operations of Amarantus Diagnostics and Theranostics Health have consolidated into Avant Diagnostics (OTCQB:AVDX)Diagnostics pipeline in Alzheimer’s disease (LymPro Test™), Ovarian cancer (OvaDx™) and...
Amarantus Enters into Letter of Intent to Merge Diagnostics Business Unit into Avant Diagnostics
19 janv. 2016 09h00 HE
|
Avant Diagnostics, Inc.
SAN FRANCISCO and SCOTTSDALE, Ariz., Jan. 19, 2016 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQX:AMBS), a biotechnology company developing products in Regenerative Medicine,...
Avant Diagnostics to Attend 12th Annual Noble Capital Markets Conference
15 janv. 2016 09h00 HE
|
Avant Diagnostics, Inc.
SCOTTSDALE, Ariz., Jan. 15, 2016 (GLOBE NEWSWIRE) -- Avant Diagnostics, Inc. (OTCQB:AVDX), "Avant", announces that CEO Gregg Linn will be presenting at the NobleCon12 - Noble Financial Capital...
Avant Diagnostics Inc. Receives FDA IRB Approval for OvaDx(R) Ovarian Cancer Validation Test Specimens
07 oct. 2015 08h00 HE
|
Avant Diagnostics, Inc.
SCOTTSDALE, Ariz., Oct. 07, 2015 (GLOBE NEWSWIRE) -- Avant Diagnostics, Inc. (OTCQB:AVDX) (“Avant”), an innovative in vitro diagnostics company, was notified by DOCRO, its independent clinical...
Avant Diagnostics Inc. Commences OvaDx(R) Ovarian Cancer Test Calibration in Preparation for FDA Submission
24 sept. 2015 10h24 HE
|
Avant Diagnostics, Inc.
SCOTTSDALE, Ariz., Sept. 24, 2015 (GLOBE NEWSWIRE) -- Avant Diagnostics, Inc. (OTCQB:AVDX) ("Avant"), an innovative molecular diagnostics company, began calibration testing in preparation for the...